Your browser doesn't support javascript.
loading
CACA Guidelines for Holistic Integrative Management of Breast Cancer.
Wu, Jiong; Fan, Daiming; Shao, Zhimin; Xu, Binghe; Ren, Guosheng; Jiang, Zefei; Wang, Yongsheng; Jin, Feng; Zhang, Jin; Zhang, Qingyuan; Ma, Fei; Ma, Jinli; Wang, Zhonghua; Wang, Shusen; Wang, Xiaojia; Wang, Shu; Wang, Haibo; Wang, Tao; Wang, Xiang; Wang, Jing; Wang, Jia; Wang, Biyun; Fu, Li; Li, Hongyuan; Shi, Yehui; Gan, Lu; Liu, Yunjiang; Liu, Jian; Liu, Zhenzhen; Liu, Qiang; Sun, Qiang; Cheng, Wenwu; Yu, Keda; Tong, Zhongsheng; Wu, Xinhong; Song, Chuangui; Zhang, Jianguo; Zhang, Jian; Li, Junjie; Li, Bin; Li, Man; Li, Huiping; Yang, Wentao; Yang, Hongjian; Yang, Benlong; Bu, Hong; Shen, Juping; Shen, Zhenzhou; Chen, Yiding; Chen, Ceshi.
Afiliação
  • Wu J; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Fan D; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Shao Z; Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Xu B; State key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
  • Ren G; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Jiang Z; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wang Y; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jin F; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing China.
  • Zhang J; Medicine-Oncology, The Affiliated Hospital of Military Medical Sciences (The 307th Hospital of Chinese People's Liberation Army), Beijing, China.
  • Zhang Q; Breast Disease Center, Shandong Cancer Hospital, Jinan, China.
  • Ma F; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Ma J; The 3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China.
  • Wang Z; Harbin Medical University Cancer Hospital, Harbin, China.
  • Wang S; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang X; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wang S; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wang H; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wang T; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Wang X; Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Wang J; Zhejiang Cancer Hospital, Hangzhou, China.
  • Wang J; Breast Center, Peking University People's Hospital, Beijing, China.
  • Wang B; Department of Breast Center, The Affiliated Hospital of Qingdao University, Shandong, China.
  • Fu L; Department of Oncology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Li H; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Shi Y; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Gan L; Department of Breast Surgery, Institute of Breast Disease, The Second Hospital of Dalian Medical University, Dalian, Liaoning China.
  • Liu Y; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Liu J; Department of Medical Oncology, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Liu Z; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Liu Q; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
  • Sun Q; State Key Laboratory of Breast Cancer Research, Tianjin, China.
  • Cheng W; Department of the Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
  • Yu K; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
  • Tong Z; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Wu X; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Song C; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Zhang J; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zhang J; Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li J; Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang China.
  • Li B; Department of Breast Disease, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Li M; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Li H; Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Yang W; Department of Breast Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Yang H; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Yang B; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Bu H; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
  • Shen J; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Shen Z; Department of Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Chen Y; Hubei Provincial Clinical Research Center for Breast Cancer, Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chen C; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Holist Integr Oncol ; 1(1): 7, 2022.
Article em En | MEDLINE | ID: mdl-37520336
ABSTRACT

Purpose:

Breast cancer is now the most common malignant tumor worldwide. About one-fourth of female cancer patients all over the world suffer from breast cancer. And about one in six female cancer deaths worldwide is caused by breast cancer. In terms of absolute numbers of cases and deaths, China ranks first in the world. The CACA Guidelines for Holistic Integrative Management of Breast Cancer were edited to help improve the diagnosis and comprehensive treatment in China.

Methods:

The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to classify evidence and consensus.

Results:

The CACA Guidelines for Holistic Integrative Management of Breast Cancer include the epidemiology of breast cancer, breast cancer screening, breast cancer diagnosis, early breast cancer treatment, advanced breast cancer treatment, follow-up, rehabilitation, and traditional Chinese medicine treatment of breast cancer patients.

Conclusion:

We to standardize the diagnosis and treatment of breast cancer in China through the formulation of the CACA Guidelines.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article